INIT.ST实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 23:29):

Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system...

Stats
今日成交量	50 199.00
平均成交量	31 532.00
市值	464.62M
EPS	SEK0 ( 2024-02-22 )
下一个收益日期	( SEK0 ) 2024-05-10
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-9.65
ATR14	SEK0.0710 (0.81%)

Initiator Pharma A/S 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Initiator Pharma A/S 财务报表

Annual	2023
营收:	SEK0
毛利润:	SEK-23 412.00 (0.00 %)
EPS:	SEK-0.440

FY	2023
营收:	SEK0
毛利润:	SEK-23 412.00 (0.00 %)
EPS:	SEK-0.440

FY	2022
营收:	SEK0
毛利润:	SEK-38 425.00 (0.00 %)
EPS:	SEK-0.720

FY	2021
营收:	SEK0.00
毛利润:	SEK-21.63M (0.00 %)
EPS:	SEK-0.531

Financial Reports:

No articles found.

Initiator Pharma A/S

Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. It develops IP2018, a monoamine reuptake inhibitor for the treatment of psychogenic erectile dysfunction; IPED2015 to treat patients suffering from organic erectile dysfunction; and IPTN2021 for targeting an orphan drug indication in severe neuropathic pain. The company's pre-clinical stage candidates include IPNP2015 for the treatment of chronic pain; and IPDP2015 for depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.